# Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer

> **NCT00416403** · PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 35 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** fluvastatin sodium
- **PROCEDURE:** Breast Cancer Surgery Only - Arm III

## Key facts

- **NCT ID:** NCT00416403
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2007-09
- **Final completion:** 2011-06
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2012-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00416403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00416403, "Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00416403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*